Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
2(20%)
Results Posted
20%(1 trials)

Phase Distribution

Ph phase_2
2
20%
Ph phase_1
3
30%
Ph phase_4
5
50%

Phase Distribution

3

Early Stage

2

Mid Stage

5

Late Stage

Phase Distribution10 total trials
Phase 1Safety & dosage
3(30.0%)
Phase 2Efficacy & side effects
2(20.0%)
Phase 4Post-market surveillance
5(50.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

10

all time

Status Distribution
Active(3)
Completed(5)
Other(2)

Detailed Status

Completed5
unknown2
Active, not recruiting1
Enrolling by invitation1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
2
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 13 (30.0%)
Phase 22 (20.0%)
Phase 45 (50.0%)

Trials by Status

active_not_recruiting110%
enrolling_by_invitation110%
completed550%
unknown220%
recruiting110%

Recent Activity

2 active trials
Showing 5 of 10
enrolling_by_invitationphase_4

Urinary Proteomics to Guide Early Intervention to Prevent Complications in Type 2 Diabetes - a Feasibility Study

NCT06954090
active_not_recruitingphase_4

Does GLP-1RA Prevent Deterioration of Metabolic State in Prediabetic and Diabetic Patients Treated With Antipsychotic Medication?

NCT04892199
completedphase_2

Home-based Intervention With Semaglutide Treatment Of Neuroleptica-Related Prediabetes

NCT05193578
recruitingphase_4

Semaglutide Improves Metabolic Abnormalities and Fertility in Obese Infertile Women With Polycystic Ovary Syndrome

NCT05702905
completedphase_2

A Study of Efinopegdutide (MK-6024) in Participants With Nonalcoholic Fatty Liver Disease (NAFLD) (MK-6024-001)

NCT04944992
View all 10 trials

Clinical Trials (10)

Showing 10 of 10 trials
NCT06954090Phase 4

Urinary Proteomics to Guide Early Intervention to Prevent Complications in Type 2 Diabetes - a Feasibility Study

Enrolling By Invitation
NCT04892199Phase 4

Does GLP-1RA Prevent Deterioration of Metabolic State in Prediabetic and Diabetic Patients Treated With Antipsychotic Medication?

Active Not Recruiting
NCT05193578Phase 2

Home-based Intervention With Semaglutide Treatment Of Neuroleptica-Related Prediabetes

Completed
NCT05702905Phase 4

Semaglutide Improves Metabolic Abnormalities and Fertility in Obese Infertile Women With Polycystic Ovary Syndrome

Recruiting
NCT04944992Phase 2

A Study of Efinopegdutide (MK-6024) in Participants With Nonalcoholic Fatty Liver Disease (NAFLD) (MK-6024-001)

Completed
NCT05153564Phase 1

A Research Study Looking Into the Effect of Semaglutide and NNC0480 0389 on Blood Levels of a Birth Control Pill in Woman After Menopause

Completed
NCT05046873Phase 1

A Research Study Looking Into Blood Levels of Semaglutide and NNC0480-0389 When Given in the Same Injection or in Two Separate Injections in Healthy People

Completed
NCT04854083Phase 4

Semaglutide as an Adjunct to Dieting in the Treatment of Type 2 Diabetes

Unknown
NCT03598621Phase 1

A Research Study to Look at Similarity Between Semaglutide Versions in Different Injection Tools

Completed
NCT04061200Phase 4

Renal Effects of Treatment With Empagliflozin Alone or in Combination With Semaglutide in Patients With Type 2 Diabetes and Albuminuria

Unknown

All 10 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
10